Efficacy and Safety of Pneumostem® for IVH in Premature Infants (Phase 2a)

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 28, 2017

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Cell Transplantation

Interventions

DRUG

Pneumostem

direct intracerebroventricular injection of mesenchymal stem cells via ventricular tap

DRUG

Normal saline

direct intracerebroventricular injection of normal saline via ventricular tap

Trial Locations (1)

Samsung Medical Center, Seoul

All Listed Sponsors

lead

Samsung Medical Center

OTHER